VIDEO: Risankizumab linked to lower risk of serious infection than other systemic treatments
According to a recent study, risankizumab was associated with a lower risk of serious infections when compared to other systemic treatments for psoriasis.
top of page
it's where dermatology lives
bottom of page
Comments